In this study, we compared three different CTC identification/enumeration methods (CellSearch®, dual fluoro-EPISPOTPSA/FGF2 assay and CellCollector®) in a cohort of patients with localized high-risk PCa, treated with radiotherapy, combined with androgen deprivation. This evidence concerns the gene FGF2 and posterior cortical atrophy.